CSIMarket Company Name, Ticker, Customers, else..
 
Carlsmed Inc   (NASDAQ: CARL)
 

Carlsmed Inc's Suppliers Performance

CARL's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
CARL Costs vs Sales of Suppliers Growth Carlsmed Inc recorded an increase in cost of sales by 17.51 % year on year, relative to one quarter ago cost of sales fell by -15.66 % in Q1.

• More on CARL Suppliers



Carlsmed Inc recorded increase in cost of sales by 17.51 % year on year, compare to one quarter ago cost of sales fell by -15.66 % in Q1.

• More on CARL Suppliers




Carlsmed Inc's Comment on Supply Chain


The company relies on contract manufacturing organizations (CMOs) to supply Aprevo interbody implants that meet its specifications and comply with quality and regulatory requirements. The company conducts inspections and testing to ensure compliance but faces risks if CMOs fail to deliver on time or meet standards. The number of qualified CMOs is limited, and qualifying new CMOs is a complex and time-consuming process that may cause manufacturing delays. Dependence on third parties for manufacturing and premarket development activities may negatively impact profit margins, regulatory approvals, and commercialization timelines if these parties do not perform as expected or comply with regulations. Any failure in these areas could materially and adversely affect the company's business and financial condition.

Carlsmed Inc's Comment on Supply Chain


The company relies on contract manufacturing organizations (CMOs) to supply Aprevo interbody implants that meet its specifications and comply with quality and regulatory requirements. The company conducts inspections and testing to ensure compliance but faces risks if CMOs fail to deliver on time or meet standards. The number of qualified CMOs is limited, and qualifying new CMOs is a complex and time-consuming process that may cause manufacturing delays. Dependence on third parties for manufacturing and premarket development activities may negatively impact profit margins, regulatory approvals, and commercialization timelines if these parties do not perform as expected or comply with regulations. Any failure in these areas could materially and adversely affect the company's business and financial condition.







CARL's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Carlsmed Inc 418.64 65.58 -38.33 127
SUBTOTAL 0.00 0.00 0.00 -


Sources: Carlsmed Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Carlsmed Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.